On September 24, the Food and Drug Administration (FDA) convened a public advisory committee meeting to discuss safety concerns about the Essure — a permanent birth control device that is implanted in the Fallopian tubes in order to create a tissue...
Filed under: Public Health, Quality, Population Health, Featured, Drugs and Medical Technology, Long-term Services and Supports, FDA, contraceptives, medical device safety, Geisinger Health System, Essure, Obstetrics and Gynecology Devices Panel